50 Results for "

COS7 cells

" in MedChemExpress (MCE) Product Catalog:
Products (50)

50 Results for "COS7 cells" in MCE Product Catalog:

Cat. No.: HY-119416
CAS No.: 21763-71-3
Sequoiaflavone is a biflavonoid compound with multiple activities. Sequoiaflavone suppresses hepatic CYP1A1/(7-Ethoxycoumarin O-deethylase) ECOD, prevents 1-42 fibrillization (IC50 = 0.29 μM) and disaggregates amyloid fibrils (EC50 = 2.04 μM), inhibits Alternaria alternata and inhibits human recombinant PDE5A1 overexpressed in COS-7 cells (IC50 = 19.9 μM) to exert NO-independent vasodilation. Sequoiaflavone can be used in Alzheimer's disease, peripheral circulatory disorder, and antifungal research .
loading...
    loading...
Cat. No.: HY-165539
CAS No.: 221238-83-1
SMER10 is a small-molecule enhancer that can induce autophagy. SMER10 can increase the number of EGFP-LC3 positive autophagosoms in COS-7 and HeLa cells, promoting the conversion of LC3-I to autophagosome-associated LC3-II. SMER10 can efficiently promote the degradation of autophagy substrates, including the mutant huntingtin protein (EGFP-HDQ74) associated with Huntington's disease and the A53T α-synuclein protein associated with Parkinson's disease. SMER10 exerts neuroprotective effect .
loading...
    loading...
Cat. No.: HY-P11948A
Target:  

c-Myc

Research Areas:  

Others

c-Myc NLS TFA is a non-canonical nuclear localization signal (NLS) derived from the oncoprotein c-Myc, with the sequence PAAKRVKLD and containing 3 basic amino acids. c-Myc NLS TFA mediates the nuclear localization of fusion proteins, and all its regions are essential or play important roles in nuclear import. c-Myc NLS TFA can target fused pyruvate kinase to the nuclei of transfected cells .
loading...
    loading...
Cat. No.: HY-P11948
CAS No.: 253328-16-4
Target:  

c-Myc

Research Areas:  

Others

c-Myc NLS is a non-canonical nuclear localization signal (NLS) derived from the oncoprotein c-Myc, with the sequence PAAKRVKLD and containing 3 basic amino acids. c-Myc NLS mediates the nuclear localization of fusion proteins, and all its regions are essential or play important roles in nuclear import. c-Myc NLS can target fused pyruvate kinase to the nuclei of transfected cells .
loading...
    loading...
Cat. No.: HY-186017
Target:  

Clathrin

Research Areas:  

Infection

Pitstop 2c is a clathrin terminal domain inhibitor with an IC50 of 1.8 μM. Pitstop 2c blocks the binding of epsin 1 to the clathrin terminal domain and impairs epsin 1-mediated membrane curvature formation at the early stage of clathrin-mediated endocytosis (CME). Pitstop 2c enhances the clathrin-independent endocytosis of galectin-3 and alters its intracellular distribution. Pitstop 2c causes mild defects in lysosomal acidification, as well as a slight increase in mitochondrial number but a reduction in average mitochondrial size. Pitstop 2c can be used in studies related to vesicular stomatitis virus infection .
loading...
    loading...
Cat. No.: HY-115804
CAS No.: 957762-36-6
Target:  

Phosphatase

Research Areas:  

Cancer

MJE3 is a cell-permeable small-molecule phosphoglycerate mutase 1 (PGAM1) inhibitor. MJE3 is applicable to research related to breast cancer and melanoma .
loading...
    loading...
Cat. No.: HY-155940
CAS No.: 41941-66-6
Synonyms: 8CPT-cAMP
Target:  

SGK PKA

Research Areas:  

Metabolic Disease

8-(4-Chlorophenylthio)-cAMP (8CPT-cAMP) is a cell membrane-permeable cAMP analog with excellent membrane permeability, which activates Sgk kinase via phosphorylation mediated by PKA. 8-(4-Chlorophenylthio)-cAMP is hydrolyzed by intracellular enzymes to produce the active metabolite 8CPT-Ade, which induces cortisol synthesis and the expression of steroidogenic protein genes. When used in combination with insulin, 8-(4-Chlorophenylthio)-cAMP enhances the activation of Sgk; it activates the cAMP pathway to promote the proliferation and iodine uptake of thyroid cells. 8-(4-Chlorophenylthio)-cAMP can be used in studies related to metabolism and signal transduction .
loading...
    loading...
Cat. No.: HY-DY1111
CAS No.: 1539318-40-5
Target:  

DNA Stain

Research Areas:  

Neurological Disease

DFHBI-2T solution is a membrane-permeable, RNA aptamer-activated fluorescent probe (Ex/Em=500 nm/523 nm), with a Kd value of 1300 nM for the RNA aptamer Spinach2. DFHBI-2T solution binds to Spinach2, converting the fluorophore to a fluorescent state, stabilizing its planar structure to facilitate the radiative fluorescence decay pathway, and forming a complex with red-shifted excitation and emission peaks. DFHBI-2T solution can be used for RNA imaging in live cells. It is also applicable to research related to fragile X-associated tremor/ataxia syndrome .
Solvent and concentration: DMSO: 5 mM
loading...
    loading...
Cat. No.: HY-D2993
CAS No.: 1418275-35-0
Synonyms: BG-TMR
Target:  

Fluorescent Dye

Research Areas:  

Others

SNAP-TMR (BG-TMR) is a cell-permeable fluorescent dye used for visualizing SNAP fusion proteins and performing single-molecule imaging for motor movement analysis. SNAP-TMR covalently binds to the active site of the SNAP tag domain on fusion proteins, thereby reporting the presence, localization, or movement of the protein. The excitation wavelength of SNAP-TMR is 561 nm, and the maximum labeling efficiency reaches 80% .
loading...
    loading...
Cat. No.: HY-182722
CAS No.: 2388536-21-6
Target:  

Androgen Receptor JAK STAT

Research Areas:  

Cancer

UT-105 is an orally active, selective androgen receptor (AR) degrader. UT-105 binds to the N-terminal domain of AR, inhibits the transactivation of AR, blocks the recruitment of AR to androgen response elements, and induces AR degradation. UT-105 inhibits the JAK-STAT signaling pathway, including reducing the expression of interferon-stimulated genes, inhibiting the phosphorylation of STAT1 and STAT3, and blocking the recruitment of STAT1 to response elements. UT-105 exhibits anticancer activity against AR-positive triple-negative breast cancer (TNBC). UT-105 can be used in the research of selective androgen receptor modulator-resistant ER-positive breast cancer and triple-negative breast cancer .
loading...
    loading...